Article

eSight announces partnership with Gentex Corp. to develop digital eyewear

Electro-optical tech producer Gentex brings experience in automotive industry to healthcare, streamlining and enhancing production for eSight’s assistive medical devices.

Leading vision-enhancement platform, eSight, today announced a strategic partnership with Gentex, a longtime supplier of electro-optical products for the global automotive, aerospace and fire protection industries, to create the next generation of assistive wearable technology for those with degenerative eyes diseases causing visual impairment.

According to the companies, the partnership will provide scalability and affordability to the low-vision space, using advanced tech to expand production and improve access for the individuals who need it most.

“This partnership marks the next big leap forward in developing low-vision digital eyewear,” eSight Chief Commercial Officer Brian McCollum said in a statement. “Gentex’s capacity and design quality will enable mass-scale production for the next eSight device, making our technology more accessible with a sleeker design, increasing the number of lives we’re able to positively impact worldwide.”

According a news release, eSight uses a combination of hardware and software to enhance vision via a wearable device, allowing people to use the technology while at school, work, home and enjoying time with friends and family.

Gentex supplies most of the major automakers with connected-car technologies and advanced electronic features that optimize driver vision. The company develops, designs and manufactures millions of digital light sensors, imagers and custom cameras designed to help machines and people see better. Their automatic-dimming rearview mirrors, camera-based driver assistance systems and other advanced technological equipment can detect objects and track their movement to eliminate glare and shadows while optimizing vision.

Gentex Chief Technology Officer Neil Boehm noted in a the news release that the company has developed vision-related tech that enhances people’s lives.

“While medical scientists research the cause for hundreds of degenerative eye conditions, we are working with eSight to create assistive technology that helps those losing their sight be able to maintain their current lifestyle,” he said in a statement. “We are here to help eSight engineer a product that provides a clearer vision for the future.”

To learn more about eSight’s technology or to join the growing list of distributors and partners, please visit www.eSightEyewear.com. To learn more about Gentex, please visit www.gentex.com.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
© 2025 MJH Life Sciences

All rights reserved.